Abstract | OBJECTIVE: STUDY DESIGN: A nested case-control study was conducted. Baseline characteristics, general obstetric history, details of the previous CS, current delivery and maternal and neonatal outcome were analysed for 41 cases with a UR and 157 controls (no rupture). Data were extracted from 21 Dutch hospitals. RESULTS: Labour induction was more common in cases than in controls (51% vs. 25% respectively, P=0.001), and in case of induction therapy especially the use of prostaglandins ( PGE2) was more frequent in the case group (86% vs. 46%, P=0.014 for cases and controls respectively). Patients with UR had a significantly lower Bishop score (median: 2.0 vs. 4.0, P=0.005) and received more augmentation of labour compared to controls (36% vs. 18%, P=0.010). In the multivariate analysis induction with PGE2 and oxytocin, induction with PGE2 alone, and augmentation of labour were independent variables affecting the occurrence of UR (respectively OR 13.0, CI 2.3-74.2; OR 4.6, CI 1.9-11.3 and OR 2.7, CI 1.2-6.3). Forty-four percent of the ruptures can be explained by induction of labour with prostaglandins+/- oxytocin. CONCLUSION: Having studied baseline characteristics, general obstetric history, details of the previous CS and of the current delivery, we show that no factors other than the use of PGE2 (+/- oxytocin) in response to a low Bishop score, and augmentation of labour with oxytocin are associated with an increased risk for UR in women undergoing VBAC after one previous CS.
|
Authors | C H E Weimar, A C Lim, M L Bots, H W Bruinse, A Kwee |
Journal | European journal of obstetrics, gynecology, and reproductive biology
(Eur J Obstet Gynecol Reprod Biol)
Vol. 151
Issue 1
Pg. 41-5
(Jul 2010)
ISSN: 1872-7654 [Electronic] Ireland |
PMID | 20427113
(Publication Type: Journal Article, Multicenter Study)
|
Copyright | Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
|
Topics |
- Adult
- Case-Control Studies
- Dinoprostone
(administration & dosage, adverse effects)
- Female
- Humans
- Labor, Induced
(adverse effects)
- Oxytocin
(administration & dosage)
- Pregnancy
- Prospective Studies
- Risk Factors
- Uterine Rupture
(etiology)
- Vaginal Birth after Cesarean
(adverse effects)
|